Comparison of beta-adrenergic agents delivered by nebulizer vs metered dose inhaler with InspirEase in hospitalized @entity748 XXXX .

@entity748 @entity1 @entity3045 @entity13521 @entity28787
The present study was undertaken to determine if beta-agonists delivered by nebulizer provide better clinical responses than @entity13521 therapy in status asthmaticus. We divided 28 hospitalized @entity748 @entity1 into three groups. Group 1 received @entity3045 by @entity13521 with InspirEase. Group 2 received nebulized @entity3045 . Group 3 received nebulized @entity28787 . Both nebulizer regimens resulted in significant improvements in both FVC and FEV1 by 30 min after initial hospital beta-agonist treatment. No significant improvement was noted in initial spirometry in the @entity13521 with InspirEase group. In spite of the superiority of nebulizer therapy in the initial phase of hospitalization, the daily rates of spirometric improvement and duration of hospitalization were not significantly different among the three groups. Our results indicate that nebulizer therapy provides superior spirometric improvement in the initial phase of status asthmaticus. However, both @entity13521 and nebulizer regimens provided similar rates of spirometric improvement and duration of hospitalization.
